Cargando…
Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B?
More than 350 million people worldwide are persistently infected with human heptatitis B virus (HBV) and at risk to develop liver cirrhosis and hepatocellular carcinoma making long-term treatment necessary. While a vaccine is available and new antiviral drugs are being developed, elimination of pers...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004001/ https://www.ncbi.nlm.nih.gov/pubmed/21188203 http://dx.doi.org/10.1155/2010/901216 |